Amanote Research
Register
Sign In
Beta-Blocker Use in Cardiovascular Disease
British Journal of Cardiac Nursing
doi 10.12968/bjca.2018.13.10.491
Full Text
Open PDF
Abstract
Available in
full text
Date
October 2, 2018
Authors
Amie Bain
Publisher
Mark Allen Group
Related search
The Use of Glucagon and Other Antidotes in a Case of Beta-Blocker and Calcium Channel Blocker Overdose
Hong Kong Journal of Emergency Medicine
Emergency Medicine
Relationship Between Heart Failure, Concurrent Chronic Obstructive Pulmonary Disease and Beta-Blocker Use: A Danish Nationwide Cohort Study
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
Beta-Blocker Use at Discharge in Patients Hospitalized for Heart Failure Is Associated With Improved Survival
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Beta-Blocker Therapy for Retinopathy of Prematurity
Anticipated Combination of Beta-Blocker and Angiotensin-Converting Enzyme Inhibitor: New Opportunities for Optimizing Treatment of Cardiovascular Patients
HYPERTENSION
All Members of Beta Blocker House on Probation!
Journal of Thoracic and Cardiovascular Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
Inhibition of HCN Channels by Beta-Blocker Carvedilol
Biophysical Journal
Biophysics
Heart Rate and Cardiovascular Disease: An Alternative to Beta Blockers
Cardiology Research and Practice
Cardiovascular Medicine
Cardiology
Beta-Blocker Use and Clinical Outcomes After Primary Vascular Surgery: A Nationwide Propensity Score-Matched Study
Journal of Vascular Surgery
Surgery
Cardiovascular Medicine
Cardiology